Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kouichi Hiraki"'
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:405-410
Autor:
Akiyoshi Kikkawa, Junki Nakajima, Takahiko Aoyama, Aoi Miyamoto, Yoshiaki Matsumoto, Daisuke Suzuki, Kouichi Hiraki, Yumina Ako
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 24(6)
Hemodialysis (HD) is a method used to remove biogenic substances or blood components that cause disease and some drugs used by patients to treat their diseases. Therefore, dosing schedule must be planned according to HD clearance (CLHD ) when medical
Publikováno v:
YAKUGAKU ZASSHI. 135:829-833
Recently, extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been more frequently isolated from blood specimens than in the past. In this study we investigated a panel of therapeutic agents used to treat 37 patients with ESBL-produc
Autor:
Kenji Higaki, Yasuhiko Sakata, Shoichiro Ohtani, Takafumi Sugawara, Kouichi Hiraki, Mitsuya Ito, Keisuke Abe, Mariko Kochi, Miho Kohno
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 41:30-36
Autor:
Takafumi Sugawara, Shunji Matsumoto, Nobue Uetake, Shinichi Miyamori, Ryouichi Okamoto, Noritaka Murakami, Kouichi Hiraki
Publikováno v:
YAKUGAKU ZASSHI. 134:433-438
The Guidelines for Management of Deep-seated Mycoses 2007 recommend the use of micafungin as a first-line agent for the treatment of candidemia. On the package insert, the recommended dose of micafungin is 50 mg/d. However, the Guidelines recommend a
Autor:
Yasuhiko Sakata, Shinichi Miyamori, Junya Inata, Yasuo Iwamoto, Masashi Kanehara, Kouichi Hiraki, Keisuke Abe
Publikováno v:
YAKUGAKU ZASSHI. 133:1209-1213
Various factors, including renal function and the combination of nonsteroidal anti-inflammatory drugs, influence the pharmacokinetics of pemetrexed. In this study, we aimed to determine the risk factors for severe adverse events associated with pemet
Autor:
Michio Kitajima, Khaleque Newaz Khan, Shiko Yoshida, Ayumi Matumoto, Daisuke Nakayama, Hideaki Masuzaki, Hiroyuki Araki, Kouhei Kotera, Kouichi Hiraki, Akira Fujihita
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 29:239-244
Autor:
Nobue Uetake, Takafumi Sugawara, Ryouichi Okamoto, Shunji Matsumoto, Shinichi Miyamori, Kouichi Hiraki, Noritaka Murakami
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 38:715-722
Autor:
Shoichiro Ohtani, Megumi Akagi, Shinichi Miyamori, Takashi Saika, Takafumi Sugawara, Yasuo Iwamoto, Kenji Higaki, Jun Noma, Mitsuya Ito, Keisuke Abe, Yasuhiko Sakata, Motoki Ninomiya, Kouichi Hiraki
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 38:780-784
Autor:
Souichi Kitaguchi, Shinichi Miyamori, Masaaki Noda, Yasuhiko Sakata, Yasuki Tomoda, Chie Hamai, Kouichi Hiraki, Utae Yonezawa, Nobue Uetake, Hidetaka Sumiyoshi, Yasuo Iwamoto
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:717-722
Nausea and vomiting due to chemotherapy not only reduce quality of life but also cause suspension or extension of therapy,or reductions in the dosages of agents used,and influence therapeutic effects.Their control is therefore extremely important.In